Atlas Trials

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

Clinical trial NCT00625326 · COMPLETED

Trial details

NCT number
NCT00625326
Sponsor
Deltanoid Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Plaque-type Psoriasis
Start date
2008-01-01
Primary completion
2008-12-01
Enrollment
321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.